|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
US4485045A
(en)
|
1981-07-06 |
1984-11-27 |
Research Corporation |
Synthetic phosphatidyl cholines useful in forming liposomes
|
|
US4544545A
(en)
|
1983-06-20 |
1985-10-01 |
Trustees University Of Massachusetts |
Liposomes containing modified cholesterol for organ targeting
|
|
US5444156A
(en)
|
1985-07-12 |
1995-08-22 |
Temple University-Of The Commonwealth System Of Higher Education |
Monoclonal antibodies to human plasma prekallikrein
|
|
US4777127A
(en)
|
1985-09-30 |
1988-10-11 |
Labsystems Oy |
Human retrovirus-related products and methods of diagnosing and treating conditions associated with said retrovirus
|
|
GB8601597D0
(en)
|
1986-01-23 |
1986-02-26 |
Wilson R H |
Nucleotide sequences
|
|
EP0296171A4
(fr)
|
1986-03-03 |
1989-11-07 |
Brigham & Womens Hospital |
Procede d'evaluation de la nephrotoxicite.
|
|
US4704692A
(en)
|
1986-09-02 |
1987-11-03 |
Ladner Robert C |
Computer based system and method for determining and displaying possible chemical structures for converting double- or multiple-chain polypeptides to single-chain polypeptides
|
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
IL85035A0
(en)
|
1987-01-08 |
1988-06-30 |
Int Genetic Eng |
Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
|
|
GB8702816D0
(en)
|
1987-02-07 |
1987-03-11 |
Al Sumidaie A M K |
Obtaining retrovirus-containing fraction
|
|
US5219740A
(en)
|
1987-02-13 |
1993-06-15 |
Fred Hutchinson Cancer Research Center |
Retroviral gene transfer into diploid fibroblasts for gene therapy
|
|
US5422120A
(en)
|
1988-05-30 |
1995-06-06 |
Depotech Corporation |
Heterovesicular liposomes
|
|
AP129A
(en)
|
1988-06-03 |
1991-04-17 |
Smithkline Biologicals S A |
Expression of retrovirus gag protein eukaryotic cells
|
|
US5045452A
(en)
|
1988-09-02 |
1991-09-03 |
Brigham And Women's Hospital |
Method for evaluating nephrotoxicity
|
|
EP0454781B1
(fr)
|
1989-01-23 |
1998-12-16 |
Chiron Corporation |
Cellules de recombinaison pour des therapies d'infections et de troubles hyperproliferatifs et la preparation de ces cellules
|
|
DE69032284T2
(de)
|
1989-03-21 |
1998-10-08 |
Vical, Inc., San Diego, Calif. |
Expression von exogenen polynukleotidsequenzen in wirbeltieren
|
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
|
WO1991002805A2
(fr)
|
1989-08-18 |
1991-03-07 |
Viagene, Inc. |
Retrovirus de recombinaison apportant des constructions de vecteur a des cellules cibles
|
|
US5585362A
(en)
|
1989-08-22 |
1996-12-17 |
The Regents Of The University Of Michigan |
Adenovirus vectors for gene therapy
|
|
US5013556A
(en)
|
1989-10-20 |
1991-05-07 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
ZA911974B
(en)
|
1990-03-21 |
1994-08-22 |
Res Dev Foundation |
Heterovesicular liposomes
|
|
US5427908A
(en)
|
1990-05-01 |
1995-06-27 |
Affymax Technologies N.V. |
Recombinant library screening methods
|
|
ES2197145T3
(es)
|
1991-08-20 |
2004-01-01 |
The Government Of The Usa As Represented By The Secretary Of The Deptm. Of Health And Human Services |
Transferencia de genes mediada por adenovirus al gastrointestinal.
|
|
US5565332A
(en)
|
1991-09-23 |
1996-10-15 |
Medical Research Council |
Production of chimeric antibodies - a combinatorial approach
|
|
WO1993010218A1
(fr)
|
1991-11-14 |
1993-05-27 |
The United States Government As Represented By The Secretary Of The Department Of Health And Human Services |
Vecteurs comprenant des genes etrangers et des marqueurs selectifs negatifs
|
|
GB9125623D0
(en)
|
1991-12-02 |
1992-01-29 |
Dynal As |
Cell modification
|
|
FR2688514A1
(fr)
|
1992-03-16 |
1993-09-17 |
Centre Nat Rech Scient |
Adenovirus recombinants defectifs exprimant des cytokines et medicaments antitumoraux les contenant.
|
|
US5733743A
(en)
|
1992-03-24 |
1998-03-31 |
Cambridge Antibody Technology Limited |
Methods for producing members of specific binding pairs
|
|
WO1993025234A1
(fr)
|
1992-06-08 |
1993-12-23 |
The Regents Of The University Of California |
Procedes et compositions permettant de cibler des tissus specifiques
|
|
WO1993025698A1
(fr)
|
1992-06-10 |
1993-12-23 |
The United States Government As Represented By The |
Particules vecteurs resistantes a l'inactivation par le serum humain
|
|
GB2269175A
(en)
|
1992-07-31 |
1994-02-02 |
Imperial College |
Retroviral vectors
|
|
CA2592997A1
(fr)
|
1992-12-03 |
1994-06-09 |
Genzyme Corporation |
Vecteurs pseudo-adenoviraux
|
|
US5981568A
(en)
|
1993-01-28 |
1999-11-09 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
|
JP3545403B2
(ja)
|
1993-04-22 |
2004-07-21 |
スカイファルマ インコーポレイテッド |
医薬化合物を被包しているシクロデキストリンリポソーム及びその使用法
|
|
EP0705344B8
(fr)
|
1993-06-24 |
2006-05-10 |
Advec Inc. |
Vecteurs a base d'adenovirus destines a la therapie genique
|
|
US6015686A
(en)
|
1993-09-15 |
2000-01-18 |
Chiron Viagene, Inc. |
Eukaryotic layered vector initiation systems
|
|
EP0694070B1
(fr)
|
1993-09-15 |
2002-04-10 |
Chiron Corporation |
Vecteurs composes d'alphavirus recombinants
|
|
BR9407956A
(pt)
|
1993-10-25 |
1996-11-26 |
Canji Inc |
Composiçao farmacêutica vetor de express o de adenovirus recombinante e kit par reduzir a proliferaçao de células tumorais
|
|
NZ276305A
(en)
|
1993-11-16 |
1997-10-24 |
Depotech Corp |
Controlled release vesicle compositions
|
|
US5795954A
(en)
|
1994-03-04 |
1998-08-18 |
Genentech, Inc. |
Factor VIIa inhibitors from Kunitz domain proteins
|
|
JP4303315B2
(ja)
|
1994-05-09 |
2009-07-29 |
オックスフォード バイオメディカ（ユーケー）リミテッド |
非交差性レトロウイルスベクター
|
|
WO1996017072A2
(fr)
|
1994-11-30 |
1996-06-06 |
Chiron Viagene, Inc. |
Vecteurs d'alphavirus de recombinaison
|
|
US6265150B1
(en)
|
1995-06-07 |
2001-07-24 |
Becton Dickinson & Company |
Phage antibodies
|
|
AU2998597A
(en)
|
1996-05-06 |
1997-11-26 |
Chiron Corporation |
Crossless retroviral vectors
|
|
DE19632772A1
(de)
|
1996-08-14 |
1998-02-19 |
Basf Ag |
Neue Benzamidine
|
|
GB9809951D0
(en)
|
1998-05-08 |
1998-07-08 |
Univ Cambridge Tech |
Binding molecules
|
|
WO2000053211A2
(fr)
|
1999-03-09 |
2000-09-14 |
University Of Southern California |
Methode de stimulation de la proliferation de myocytes et de la reparation des tissus myocardiques
|
|
KR100913714B1
(ko)
|
2001-11-08 |
2009-08-24 |
패시트 바이오테크 코포레이션 |
Ｉｇｇ 항체의 안정한 액상 약학 제형물
|
|
US7132100B2
(en)
|
2002-06-14 |
2006-11-07 |
Medimmune, Inc. |
Stabilized liquid anti-RSV antibody formulations
|
|
US20070253949A1
(en)
|
2004-02-03 |
2007-11-01 |
Stefan Golz |
Diagnostics and Therapeutics for Diseases Associated with Plasma Kallikrein (KLKB1)
|
|
WO2006017538A2
(fr)
|
2004-08-03 |
2006-02-16 |
Dyax Corp. |
Proteines de liaison a la proteine hk1
|
|
US7235530B2
(en)
|
2004-09-27 |
2007-06-26 |
Dyax Corporation |
Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
|
|
JP5337493B2
(ja)
|
2006-03-16 |
2013-11-06 |
ダイアックス コーポレーション |
セリンプロテアーゼを阻害するペプチドを用いて眼科障害を治療する組成物及び方法
|
|
KR100846354B1
(ko)
*
|
2007-03-21 |
2008-07-15 |
(주) 프로탄바이오 |
혈청 당단백질부터 분리한 폐암 진단용 마커
|
|
US20090105142A1
(en)
*
|
2007-08-23 |
2009-04-23 |
Genzyme Corporation |
Treatment with kallikrein inhibitors
|
|
CN101928346B
(zh)
|
2009-07-31 |
2013-01-16 |
华中科技大学同济医学院附属同济医院 |
一种抗人组织激肽释放酶单克隆抗体及其制备
|
|
RS62853B1
(sr)
|
2010-01-06 |
2022-02-28 |
Takeda Pharmaceuticals Co |
Proteini koji vezuju kalikrein plazme
|
|
AU2012204202A1
(en)
*
|
2011-01-06 |
2013-07-11 |
Dyax Corp. |
Plasma kallikrein binding proteins
|
|
US8691861B2
(en)
|
2011-04-13 |
2014-04-08 |
Activesite Pharmaceuticals, Inc. |
Prodrugs of inhibitors of plasma kallikrein
|
|
KR102014512B1
(ko)
|
2011-05-02 |
2019-08-26 |
밀레니엄 파머슈티컬스 인코퍼레이티드 |
항-α4β7 항체에 대한 제형
|
|
JP6345123B2
(ja)
|
2012-02-16 |
2018-06-20 |
サンタラス， インコーポレイテッド |
抗ｖｌａ１（ｃｄ４９ａ）抗体医薬組成物
|
|
US9216219B2
(en)
|
2012-06-12 |
2015-12-22 |
Novartis Ag |
Anti-BAFFR antibody formulation
|
|
KR102523810B1
(ko)
|
2013-01-20 |
2023-04-21 |
다케다 파머수티컬 컴패니 리미티드 |
브래디키닌 매개 장애의 평가 및 치료
|
|
HUE044285T2
(hu)
|
2013-01-20 |
2019-10-28 |
Dyax Corp |
PKal-mediálta rendellenességek értékelése, vizsgálata és kezelése
|
|
US20160017055A1
(en)
|
2013-03-15 |
2016-01-21 |
Dyax Corp. |
Anti-plasma kallikrein antibodies
|
|
KR20140119396A
(ko)
|
2013-03-29 |
2014-10-10 |
삼성전자주식회사 |
단백질 약물의 액상 제형
|
|
ES2856076T3
(es)
|
2014-01-21 |
2021-09-27 |
Takeda Pharmaceuticals Co |
Proteínas de unión a calicreína plasmática y usos de las mismas en el tratamiento de angioedema hereditario
|
|
CN106459210A
(zh)
|
2014-03-27 |
2017-02-22 |
戴埃克斯有限公司 |
用于治疗糖尿病黄斑性水肿的组合物和方法
|
|
MX2017012423A
(es)
|
2015-03-30 |
2018-01-26 |
Dyax Corp |
Inhibidores de calicreina plasmatica y uso de los mismos para prevenir el ataque del angioedema hereditario.
|
|
US11286307B2
(en)
|
2015-12-11 |
2022-03-29 |
Takeda Pharmaceutical Company Limited |
Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack
|
|
JP2021535161A
(ja)
|
2018-08-30 |
2021-12-16 |
ダイアックス コーポレーション |
血漿カリクレイン阻害剤及び遺伝性血管浮腫発作を処置するためのその使用
|
|
WO2020186132A1
(fr)
|
2019-03-14 |
2020-09-17 |
Dyax Corp. |
Traitement d'une crise d'angio-œdème héréditaire avec une dose réduite d'anticorps se liant à la kallicréine plasmatique humaine
|